Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spirographic AI is a medical technology company specializing in the development of artificial intelligence solutions for respiratory health diagnostics. The company's primary platform utilizes advanced machine learning algorithms to analyze and interpret spirometry data, providing clinicians with automated, high-accuracy insights into pulmonary function tests (PFTs). By identifying subtle patterns in spirograms, the technology assists in the early detection and management of chronic respiratory conditions such as asthma and COPD. Spirographic AI aims to standardize respiratory care and reduce the diagnostic burden on healthcare providers through its cloud-based diagnostic support tools. The platform is designed to integrate into existing clinical workflows, ensuring that complex lung function data is accessible and actionable for primary care physicians and specialists alike.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spirographic AI.